News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Response Genetics, Inc. Release: FDA-Cleared, Medicare-Reimbursed, Responsedx: Tissue Of Origin™ Test Added To National Institutes of Health (NIH) Genetic Testing Registry


6/12/2014 7:43:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES, June 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy selection, today announced that the National Institutes of Health (NIH) Genetic Testing Registry (GTR), a searchable database of genetic and genomic tests, has been updated to include the recently introduced ResponseDX: Tissue of OriginTM test. Response Genetics acquired this test as part of its acquisition of the assets of the former PathWork Diagnostics in late 2013 and introduced the test, the only FDA-cleared test of its kind, to the market in February 2014. The GTR offers detailed clinical and scientific information about testing options for physicians and patients.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES